Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Public ClinicalTrials.gov record NCT03488563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Study identification
- NCT ID
- NCT03488563
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AOBiome LLC
- Industry
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Interventions
- B244 Biological
- Vehicle Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2018
- Primary completion
- Jun 16, 2019
- Completion
- Jul 15, 2019
- Last update posted
- Oct 3, 2022
2018 – 2019
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Collaborative Neuroscience Network, LLC | Long Beach | California | 90806 | — |
| CI Trials | Riverside | California | 92506 | — |
| Neurological Research Institute | Santa Monica | California | 90404 | — |
| New England Institute for Neurology and Headache (NEINH)/Medical Practice | Stamford | Connecticut | 06905 | — |
| Clinical Neuroscience Solution, Inc | Jacksonville | Florida | 32256 | — |
| Precision Clinical Research | Lauderdale Lakes | Florida | 33319 | — |
| Clinical Neuroscience Solution, Inc | Orlando | Florida | 32801 | — |
| Palm Beach Research | West Palm Beach | Florida | 33409 | — |
| Neurostudies Clinical Research | Decatur | Georgia | 30033 | — |
| BTC of New Bedford | New Bedford | Massachusetts | 02740 | — |
| MedVadis Research | Watertown | Massachusetts | 02472 | — |
| Altea Research Institute | Las Vegas | Nevada | 89102 | — |
| Rochester Clinical Research INC | Rochester | New York | 14609 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29406 | — |
| Clinical Neuroscience Solution, Inc | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials of Neurology and Sleep Lab, L.P. | Austin | Texas | 78731 | — |
| FutureSearch Trials of Dallas, L.P. | Dallas | Texas | 75231 | — |
| Texas Center for Drug Development | Houston | Texas | 77081 | — |
| Charlottesville Medical Research | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03488563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03488563 live on ClinicalTrials.gov.